Salidroside
- Half-Life (t½)
- PO: 1.2h
- Formula
- C14H20O7
- Molecular Weight
- 300.3 g/mol
- Aliases
- Rhodioloside, 2-(4-Hydroxyphenyl)ethyl β-D-glucoside
Pharmacological Mechanism
Tyrosol glucoside — the principal active adaptogen of Rhodiola rosea. Crosses BBB (brain-to-plasma AUC ~0.2 in rats). Mechanisms: PI3K/AKT activation, AMPK induction, Nrf2-mediated antioxidant response, NF-κB inhibition, and modest monoamine-oxidase inhibition contributing to the fast-onset antifatigue / antidepressant signal. Rat PK: Cmax ~6–12 µg/mL after 25 mg/kg oral at Tmax 0.5 h, t½ 1.5–2.5 h, absolute bioavailability 51–98% depending on dose (Fan 2020 review). Hepatic UGT-mediated glucuronidation dominant elimination route. No definitive human PK published.
Half-Life & Elimination Curve (PO: 1.2h)
Elimination (PO)
- 0×t½0h100%
- 1×t½1.2h50%
- 2×t½2.4h25%
- 3×t½3.6h12.5%
- 4×t½4.8h6.3%
- 5×t½6h3.1%
Dosing Guidelines
- Oral (PO): Typical 333 mg (Range: 200–600 mg)
Pharmacokinetic Parameters
Pathways It Modulates
Target Organ Systems
Chemical Structure & Identifiers
- InChIKey: ILRCGYURZSFMEG-RKQHYHRCSA-N
- SMILES: C1=CC(=CC=C1CCO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O
References